DT vs. EW
DT (Dynatrace, Inc.) and EW (Edwards Lifesciences Corporation) are both stocks. DT operates in Software - Application (Technology), while EW operates in Medical Devices (Healthcare). Over the past 5 years, DT returned -5.97%/yr vs -3.17%/yr for EW. At a 0.35 correlation, their price movements are largely independent.
Performance
DT vs. EW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DT achieves a -5.98% return, which is significantly lower than EW's -0.16% return.
DT
- 1D
- 0.94%
- 1M
- 6.23%
- YTD
- -5.98%
- 6M
- -11.49%
- 1Y
- -23.16%
- 3Y*
- -7.55%
- 5Y*
- -5.97%
- 10Y*
- —
EW
- 1D
- -0.76%
- 1M
- 4.58%
- YTD
- -0.16%
- 6M
- 2.44%
- 1Y
- 13.25%
- 3Y*
- -0.88%
- 5Y*
- -3.17%
- 10Y*
- 9.72%
DT vs. EW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
DT Dynatrace, Inc. | -5.98% | -20.26% | -0.62% | 42.79% | -36.54% | 39.47% | 71.03% | -0.78% |
EW Edwards Lifesciences Corporation | -0.16% | 15.16% | -2.91% | 2.20% | -42.41% | 42.00% | 17.32% | 9.60% |
Correlation
The correlation between DT and EW is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Aug 1, 2019 | 0.35 |
Over the past year, the correlation between DT and EW has dropped to 0.06 - well below their long-term average of 0.35, suggesting their price drivers have been diverging.
Fundamentals
DT:
$12.18B
EW:
$49.42B
DT:
$0.73
EW:
$1.87
DT:
55.69
EW:
45.49
DT:
0.77
EW:
1.46
DT:
6.11
EW:
7.89
DT:
4.66
EW:
4.79
DT:
$2.02B
EW:
$6.30B
DT:
$1.65B
EW:
$4.92B
DT:
$289.14M
EW:
$1.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DT vs. EW — Risk / Return Rank
DT
EW
DT vs. EW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dynatrace, Inc. (DT) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DT | EW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.13 | ||
| Sortino ratioReturn per unit of downside risk | -1.61 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.11 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.58 | 0.96 | -1.53 |
| Martin ratioReturn relative to average drawdown | -1.01 | 2.37 | -3.38 |
Loading charts...
Drawdowns
DT vs. EW - Drawdown Comparison
The maximum DT drawdown since its inception was -61.77%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for DT and EW.
Loading charts...
Drawdown Indicators
| DT | EW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.77% | -54.32% | -7.45% |
Max Drawdown (1Y)Largest decline over 1 year | -42.87% | -12.73% | -30.14% |
Max Drawdown (3Y)Largest decline over 3 years | -48.16% | -37.53% | -10.63% |
Max Drawdown (5Y)Largest decline over 5 years | -61.77% | -54.32% | -7.45% |
Max Drawdown (10Y)Largest decline over 10 years | — | -54.32% | — |
Current DrawdownCurrent decline from peak | -48.26% | -34.87% | -13.39% |
Average DrawdownAverage peak-to-trough decline | -30.74% | -14.48% | -16.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.41% | 5.15% | +19.26% |
Volatility
DT vs. EW - Volatility Comparison
Dynatrace, Inc. (DT) has a higher volatility of 14.37% compared to Edwards Lifesciences Corporation (EW) at 6.36%. This indicates that DT's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DT | EW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.37% | 6.36% | +8.01% |
Volatility (6M)Calculated over the trailing 6-month period | 33.53% | 18.73% | +14.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.53% | 24.12% | +15.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.76% | 32.60% | +8.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.56% | 32.25% | +14.31% |
Dividends
DT vs. EW - Dividend Comparison
Neither DT nor EW has paid dividends to shareholders.
Financials
DT vs. EW - Financials Comparison
This section allows you to compare key financial metrics between Dynatrace, Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DT vs. EW - Profitability Comparison
DT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dynatrace, Inc. reported a gross profit of 430.32M and revenue of 531.72M. Therefore, the gross margin over that period was 80.9%.
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.
DT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dynatrace, Inc. reported an operating income of 37.34M and revenue of 531.72M, resulting in an operating margin of 7.0%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.
DT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dynatrace, Inc. reported a net income of 76.21M and revenue of 531.72M, resulting in a net margin of 14.3%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.
Frequently Asked Questions
DT and EW have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DT has higher volatility (14.37%) compared to EW (6.36%). In terms of maximum drawdown, DT dropped -61.77% vs EW's -54.32%.
EW currently has the higher Sharpe Ratio (0.51 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DT and EW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer